A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk].
For additional information, please contact the Research Nurses:
- Caroline DePiano, RN, MSN; 610-738-2522
- Susan Metzger, RN, MSN; 610-738-2515
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum.
For additional information, please contact the Research Nurses:
- Caroline DePiano, RN, MSN; 610-738-2522
- Susan Metzger, RN, MSN; 610-738-2515
A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) or pertuzumab trastuzumab and hyaluronidase-zzfx (PHESGO) in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma.
For additional information, please contact the Research Nurses:
- Caroline DePiano, RN, MSN; 610-738-2522
- Susan Metzger, RN, MSN; 610-738-2515